[Properties and indications of potassium-sparing diuretics].
D000584:Amiloride / Q000008:administration & dosage / Q000627:therapeutic use; D004232:Diuretics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D006852:Hydrochlorothiazide / Q000008:administration & dosage / Q000627:therapeutic use; D006929:Hyperaldosteronism / Q000188:drug therapy; D006973:Hypertension / Q000188:drug therapy; D007008:Hypokalemia / Q000188:drug therapy / Q000517:prevention & control; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D013148:Spironolactone / Q000008:administration & dosage / Q000627:therapeutic use; D014223:Triamterene / Q000008:administration & dosage / Q000627:therapeutic use
D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D006852:Hydrochlorothiazide; D013148:Spironolactone; D000584:Amiloride; D014223:Triamterene
Propriétés et indications des diurétiques d'épargne potassique.